Tag: Vektor Medical

Vektor Medical Completes Enrollment in IMPRoVED-AF Clinical Study and Announces Appointment of Brandon Allen as Senior Vice President of Sales

Regulatory Rhythm by 0 comments

SAN DIEGO–(BUSINESS WIRE)– #Medtech–Vektor Medical, a medical technology company advancing the treatment of cardiac arrhythmias through its non-invasive, AI-based arrhythmia analysis technology, vMap®, today announced the completion of patient enrollment in its IMPRoVED-AF randomized clinical study and the appointment of Brandon Allen as Senior Vice President of Sales. Together, these milestones mark important progress in Vektor’s efforts to expand commercial adoption of vMap and strengthen the clinica

Continue Reading →

Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe

Regulatory Rhythm by 0 comments

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced it has received CE Mark for the vMap® System, a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute. “vMap is emerging as a simple, non-invasive […]

Continue Reading →

Vektor Medical Announces Patient Enrollment in VITAL-EP Study Evaluating vMap-Guided Ablations

Rhythm by 0 comments

First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent’s has enrolled the first patient in the VITAL-EP study. The study is designed to evaluate the procedural efficacy, acute success, and workflow […]

Continue Reading →

Vektor Medical Names Kelly Perez as CFO and SVP of Operations to Support Expanding vMap Adoption

Financial by 0 comments

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the appointment of Kelly Perez as Chief Financial Officer (CFO) and Senior Vice President of Operations, strengthening its leadership team as adoption of vMap accelerates. Perez will help guide Vektor’s financial strategy and operations to support […]

Continue Reading →

Vektor Medical’s vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care

Rhythm by 0 comments

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient outcomes. As adoption of PFA accelerates, the need […]

Continue Reading →

Vektor Medical Announces Post-Market Study Evaluating Benefit of AI-Powered Analysis to Identify and Ablate Non-Pulmonary Vein AF Targets

Rhythm by 0 comments

MPRoVED AF RCT and VITAL-EP Registry Reinforce Vektor’s Focus on Data That Drives EP Adoption and Ablation Outcomes SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the IMPRoVED AF clinical study designed to evaluate the benefit of utilizing AI-driven mapping to […]

Continue Reading →

The Future of AI & Electrophysiology Takes Center Stage at Heart Rhythm 2025 with Vektor Medical

Rhythm by 0 comments

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will showcase its transformative vMap technology at Heart Rhythm 2025, taking place April 25–27 in San Diego. Through live demonstrations at adjacent booths (#1523 and #1622), scientific abstract presentations, and a highly anticipated Rhythm Theater session featuring leading […]

Continue Reading →

Vektor Medical Strengthens Leadership Team to Accelerate Commercial Growth and Market Expansion

Financial by 0 comments

Corporate Update to be Presented at LSI USA SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced key leadership appointments to support commercial expansion and market entry initiatives. Michael Andersen has joined the company as Vice President, Sales, and Mihir Naik has been promoted to […]

Continue Reading →

New Data Demonstrates Vektor Medical’s AI-Powered vMap Algorithm Achieves 91% Accuracy in Distinguishing Epicardial and Endocardial Ventricular Tachycardia, Markedly Surpassing Visual ECG Analysis

Rhythm by 0 comments

CHICAGO–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive arrhythmia analysis and localization, announced today the presentation of new data showcasing the significant capabilities of vMap, its AI-powered solution for enhancing cardiac arrhythmia treatment. To be presented on November 17 at the American Heart Association (AHA) Scientific Sessions 2024, this data highlights […]

Continue Reading →

Vektor Medical Unveils Groundbreaking Research on AI and Deep Learning Innovations in Ventricular Tachycardia Analysis

Rhythm by 0 comments

September 06, 2024 07:59 AM Eastern Daylight Time ATLANTA–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will present findings today at HRX 2024. The two studies showcase how Vektor’s advanced technologies uniquely leverage AI and deep learning to assess wall thickness and scar tissue in ventricular tachycardia […]

Continue Reading →
1 2 3